Super Tadapox
$ 102,00 – $ 545,00Price range: $ 102,00 through $ 545,00
TriOmega
$ 127,00 – $ 182,00Price range: $ 127,00 through $ 182,00
Toxo-Mox
$ 55,00 – $ 151,00Price range: $ 55,00 through $ 151,00
Toxo-Mox is a highly effective broad-spectrum antibiotic designed to combat a variety of bacterial infections. This medication combines amoxicillin and potassium clavulanate to efficiently eliminate bacteria that have developed resistance to other treatments. It is commonly used to treat respiratory tract conditions such as pneumonia, bronchitis, and acute sinusitis. Additionally, Toxo-Mox is an excellent choice for managing urinary tract infections, ear infections, and various skin-related bacterial issues. By targeting the root of the infection, this potent formula helps patients achieve a faster and more complete recovery.
SKU:
Toxo-Mox
Category: Misc
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Toxo-Mox belongs to a group of combination antibacterial medications featuring an aminopenicillin alongside a beta-lactamase inhibitor. It is prescribed in the United States under strict medical supervision for treating specific bacterial infections susceptible to this combination. Dispensed in accordance with applicable federal and state regulations, this prescription therapy requires a valid order from a licensed healthcare provider.
Because inappropriate use of antibacterial agents can contribute to drug-resistant pathogens, therapy must be guided by appropriate diagnostic evaluations and professional oversight.
Pharmacological and Clinical Profile
How the drug works
The therapeutic efficacy of Toxo-Mox relies on a dual-action biochemical mechanism targeting bacterial cell wall integrity and defense systems. Amoxicillin, an aminopenicillin derivative, binds to specific penicillin-binding proteins located inside the bacterial cell wall. This inhibition blocks the final transpeptidation step of peptidoglycan synthesis, leading to osmotic instability and autolysis of susceptible bacteria. However, many pathogens produce beta-lactamase enzymes that hydrolyze the beta-lactam ring of amoxicillin, rendering it ineffective. To counter this resistance mechanism, potassium clavulanate acts as a competitive, irreversible inhibitor of many plasmid-mediated beta-lactamase enzymes. By inactivating these enzymes, clavulanate protects amoxicillin from enzymatic degradation, thereby restoring and broadening its antibacterial spectrum against beta-lactamase-producing organisms.
Main uses
Toxo-Mox is indicated for the treatment of mild-to-moderate and severe bacterial infections caused by susceptible strains of microorganisms. Clinical indications commonly include lower respiratory tract infections, such as community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis. It is also utilized in treating acute bacterial rhinosinusitis, otitis media, and soft tissue infections, including bite wounds and cellulitis. Additionally, uncomplicated urinary tract infections caused by beta-lactamase-producing enterobacteriaceae fall within its approved scope. Prescribing healthcare providers conduct culture and susceptibility testing prior to or during treatment to ensure that the causative pathogen remains responsive to this combination therapy.
Dosing schedule
The exact dosing schedule for Toxo-Mox is determined individually by the prescribing physician based on infection severity, body weight, renal function, and specific diagnosis. Oral formulations should be administered at the start of a meal to optimize clavulanate absorption and minimize gastrointestinal intolerance. Patients must complete the full prescribed course of treatment even if clinical symptoms improve early, as premature discontinuation increases the risk of therapeutic failure and antimicrobial resistance. Tablets should be swallowed whole with a full glass of water and should not be crushed or chewed unless specifically formulated as chewable variants. Adjustment of dosage intervals is required for patients exhibiting moderate to severe renal impairment.
How it’s absorbed and eliminated
Following oral administration, both amoxicillin and clavulanic acid are rapidly absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 1 to 2 hours. The presence of food does not impair amoxicillin absorption and actually enhances the bioavailability of clavulanate. Both components diffuse readily into most body tissues and fluid spaces, including lungs, middle ear fluid, pleural fluid, and skin structures, though penetration into the central nervous system is minimal unless meninges are inflamed. Amoxicillin undergoes limited hepatic metabolism, whereas clavulanic acid is extensively metabolized in the liver. Elimination occurs primarily through the kidneys via glomerular filtration and tubular secretion, with a serum elimination half-life averaging approximately 1 hour in individuals with normal renal function.
Compatibility with other medicines
Concomitant administration of Toxo-Mox with other medicinal agents requires careful evaluation to avoid altered therapeutic responses or heightened toxicity. Concurrent use with probenecid decreases renal tubular secretion of amoxicillin, resulting in elevated and prolonged serum concentrations of the antibiotic. Co-administration with oral anticoagulants, such as warfarin, may prolong prothrombin time and increase the risk of bleeding, necessitating clinical monitoring. Concurrent administration with allopurinol significantly increases the incidence of erythematous skin rashes. Furthermore, like many broad-spectrum antibacterial regimens, this drug may temporarily reduce the efficacy of combined oral contraceptives by altering intestinal microflora, making secondary barrier contraceptive methods advisable during treatment.
Adverse reactions
The safety profile of Toxo-Mox reflects reactions commonly associated with aminopenicillin combinations. The most frequently observed adverse events involve the gastrointestinal system, including diarrhea, nausea, vomiting, abdominal discomfort, and dyspepsia. Cutaneous reactions, such as maculopapular rash, urticaria, and pruritus, may also occur. Hypersensitivity reactions ranging from mild skin eruptions to severe anaphylactic responses have been documented in susceptible individuals. Extended antibiotic administration can disrupt normal microflora, predisposing patients to oral or vaginal candidiasis and Clostridioides difficile-associated diarrhea. Less common systemic effects include transient elevations in liver enzymes, eosinophilia, and mild headache.
Important precautions
Toxo-Mox is strictly contraindicated in patients with a history of severe hypersensitivity reactions to penicillins, cephalosporins, or other beta-lactam agents, as well as those with a previous history of amoxicillin/clavulanate-associated hepatic dysfunction. Serious and occasionally fatal anaphylactic reactions require immediate emergency intervention with epinephrine and airway management. Prescribers should exercise caution in patients with hepatic impairment, periodically monitoring liver function tests during prolonged therapy. Renal function must be evaluated prior to initiating treatment in elderly populations or those with known kidney disease, as dose modifications are necessary. Use during pregnancy and lactation should occur only when clearly indicated under direct medical supervision.
Food and alcohol interactions
Administering Toxo-Mox alongside a meal or light snack enhances the oral bioavailability of clavulanic acid while simultaneously reducing gastrointestinal side effects such as nausea and stomach distress. While direct pharmacological interactions with ethanol are not marked, consuming alcohol during active bacterial infections is discouraged. Alcohol consumption can impair immune responses, exacerbate dehydration, and worsen gastrointestinal upset or dizziness, potentially compromising overall recovery.
If you skip a dose
If a dose of Toxo-Mox is missed, it should be taken as soon as remembered, provided the next scheduled dose is not due shortly. If it is almost time for the subsequent dose, the missed dose should be skipped entirely, maintaining the regular administration schedule. Patients must never double the dose to compensate for a missed administration, as taking excessive amounts increases the probability of acute gastrointestinal toxicity.
Storage and expiration
Solid oral dosage forms of Toxo-Mox should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), away from excess heat, direct sunlight, and moisture. Liquid reconstitutions must be refrigerated between 36°F and 46°F (2°C to 8°C) and discarded after 10 to 14 days, according to product label instructions. Always keep medications tightly closed in their original containers out of reach of children and domestic pets.
Key Information Overview
| Parameter | Details |
|---|---|
| Active Components | Amoxicillin / Potassium Clavulanate |
| Therapeutic Class | Aminopenicillin and Beta-lactamase Inhibitor Combination |
| Route of Administration | Oral (tablets, oral suspension) |
| Prescription Status | Prescription (Rx) required |
| Primary Elimination Route | Renal excretion |
| Administration Timing | Administer at the start of a meal |
Common Questions
How long does Toxo-Mox take to show clinical improvement?
Clinical response typically begins within 24 to 48 hours after starting therapy, as bacterial loads diminish. However, symptomatic improvement does not mean the infection is fully eradicated. Patients must complete the complete duration of therapy specified by their prescriber to prevent relapse.
Can Toxo-Mox cause severe watery diarrhea?
Mild diarrhea is a known side effect due to alterations in intestinal flora. However, severe, watery, or bloody diarrhea accompanied by abdominal cramps and fever may indicate Clostridioides difficile-associated colitis. This condition requires prompt medical assessment and treatment discontinuation.
Is Toxo-Mox effective against viral infections like flu or COVID-19?
No. Antibacterial medications target bacterial structures specifically and have no pharmacological activity against viral pathogens. Using antibacterial agents for viral illnesses exposes patients to drug risks without clinical benefit and contributes to antibiotic resistance.
What should be done if an allergic reaction develops during treatment?
Any signs of acute allergic response–such as skin hives, swelling of the face, tongue, or throat, or sudden shortness of breath–require immediate cessation of the medication and urgent emergency care. Patients should inform all medical providers of any known penicillin allergies.
In accordance with FDA requirements.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
Additional information
| Dosage |
250 mg + 50 mg ,500 mg + 100 mg |
|---|---|
| Package |
30 tabs ,60 tabs ,90 tabs |
| Active Ingredient |
Amoxicillin Trihydrate, Potassium Clavulanate Diluted |
Related products
Ataxin
$ 250,00 – $ 387,00Price range: $ 250,00 through $ 387,00
More Details
This product has multiple variants. The options may be chosen on the product page
Cipcal
$ 117,00 – $ 216,00Price range: $ 117,00 through $ 216,00
More Details
This product has multiple variants. The options may be chosen on the product page
Doxypet
$ 15,00 – $ 77,00Price range: $ 15,00 through $ 77,00
More Details
This product has multiple variants. The options may be chosen on the product page
Fiprofort Spray
$ 50,00
More Details
This product has multiple variants. The options may be chosen on the product page
Ichmune C
$ 112,00 – $ 1 071,00Price range: $ 112,00 through $ 1 071,00
More Details
This product has multiple variants. The options may be chosen on the product page
Ichmune C Oral Solution
$ 150,00
More Details
This product has multiple variants. The options may be chosen on the product page
Kenadion Injection
$ 70,00 – $ 240,00Price range: $ 70,00 through $ 240,00
More Details
This product has multiple variants. The options may be chosen on the product page
Metaflam Oral Suspension
$ 38,00 – $ 77,00Price range: $ 38,00 through $ 77,00
More Details
This product has multiple variants. The options may be chosen on the product page
